Table 1.
CD4+ T cells | CD8+ T cells | |||
---|---|---|---|---|
PBS-treated | SEA-treated | PBS-treated | SEA-treated | |
IL-10 (pg/ml) | 50 | 1,500 | 25 | 100 |
TGF-β (pg/ml) | n.d. | 30 | n.d. | n.d. |
TGF-β (acid-activated, pg/ml) | n.d. | 400 | n.d. | n.d. |
IL-4 (pg/ml) | n.d. | n.d. | n.d. | n.d. |
IL-2 (U/ml) | 94 | 0.06 | 72 | 0.05 |
IFN-γ (U/ml) | >10 | 1.25 | >10 | 1.25 |
FACS®-sorted CD4+ or CD8+ T cells were stimulated for 48 h in the presence of PCC 81–104 peptide plus APCs. The supernatants were then removed and measured for cytokine production by bioassay (for determination of units/milliliter IL-2) or ELISA. Data are representative of three separate experiments. n.d., not detectable.